Eleven Biotherapeutics Logo Image

Eleven Biotherapeutics

Eleven Biotherapeutics has reached its limit for report views.

Please check back to see if Eleven Biotherapeutics has upgraded their profile page to allow their financial information to be viewed. In the meantime, here are a few annual reports from similar companies.

Most Recent Annual Report

2016 Annual Report, Interactive Annual Report and Form 10K

Eleven Biotherapeutics

Eleven Biotherapeutics does not currently have any hardcopy reports available on AnnualReports.com. Click the button below to be notified when hardcopies become available.



Archived Annual Reports

  • Eleven Biotherapeutics
  • Eleven Biotherapeutics
  • Eleven Biotherapeutics

About Eleven Biotherapeutics

11-50 Employees
Based in Cambridge, Massachusetts

Eleven Biotherapeutics, Inc. is a preclinical-stage biopharmaceutical company with a proprietary protein engineering platform, called AMP-Rx, that it applies to the discovery and development of protein therapeutics to treat diseases of the eye.

Ticker:
EBIO
Exchange:
NASDAQ (See More NASDAQ Companies)
Industry:
Biotechnology (See More Biotechnology Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol